Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 6
2005 12
2006 15
2007 17
2008 17
2009 35
2010 50
2011 71
2012 50
2013 64
2014 88
2015 87
2016 80
2017 89
2018 112
2019 101
2020 88
2021 130
2022 134
2023 138
2024 51

Text availability

Article attribute

Article type

Publication date

Search Results

1,295 results

Results by year

Filters applied: . Clear all
Page 1
In Support of Early-Career Researchers.
Bandichhor R, Borovik AS, Bettencourt-Dias A, Eastgate MD, Radu NS, Shi F, McElwee-White L. Bandichhor R, et al. Among authors: shi f. J Org Chem. 2023 Feb 17;88(4):1923-1927. doi: 10.1021/acs.joc.3c00130. Epub 2023 Feb 2. J Org Chem. 2023. PMID: 36727963 No abstract available.
In Support of Early-Career Researchers.
Bandichhor R, Borovik AS, Bettencourt-Dias A, Eastgate MD, Radu NS, Shi F, McElwee-White L. Bandichhor R, et al. Among authors: shi f. Org Lett. 2023 Feb 10;25(5):715-719. doi: 10.1021/acs.orglett.3c00187. Epub 2023 Feb 2. Org Lett. 2023. PMID: 36727953 No abstract available.
Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.
Lin Y, Qin S, Yang H, Shi F, Yang A, Han X, Liu B, Li Z, Ji Q, Tang L, Deng Z, Ding Y, Fu W, Xie X, Li L, He X, Lv Z, Ma Q, Shen Z, Guo Z, Chen Z, Cui Y, Tan J, Gao Z, Jing S, Lu K, Luo X, Zhang Y, Fang Y, Li Z, Cheng Y, Lei S, Luan S, Chen G, Wang G, Wu L, Liu L. Lin Y, et al. Among authors: shi f. Clin Cancer Res. 2023 Aug 1;29(15):2791-2799. doi: 10.1158/1078-0432.CCR-22-3613. Clin Cancer Res. 2023. PMID: 37184934 Clinical Trial.
miR-223: An Immune Regulator in Infectious Disorders.
Yuan S, Wu Q, Wang Z, Che Y, Zheng S, Chen Y, Zhong X, Shi F. Yuan S, et al. Among authors: shi f. Front Immunol. 2021 Dec 10;12:781815. doi: 10.3389/fimmu.2021.781815. eCollection 2021. Front Immunol. 2021. PMID: 34956210 Free PMC article. Review.
Extended reality for biomedicine.
Yuan J, Hassan SS, Wu J, Koger CR, Packard RRS, Shi F, Fei B, Ding Y. Yuan J, et al. Among authors: shi f. Nat Rev Methods Primers. 2023;3:15. doi: 10.1038/s43586-023-00208-z. Epub 2023 Mar 2. Nat Rev Methods Primers. 2023. PMID: 37051227 Free PMC article.
In Support of Early-Career Researchers.
Bandichhor R, Borovik AS, Bettencourt-Dias A, Eastgate MD, Radu NS, Shi F, McElwee-White L. Bandichhor R, et al. Among authors: shi f. Inorg Chem. 2023 Feb 13;62(6):2489-2493. doi: 10.1021/acs.inorgchem.3c00207. Epub 2023 Feb 2. Inorg Chem. 2023. PMID: 36727951 No abstract available.
1,295 results